Mr. Snow is a nationally recognized healthcare CEO and has an industry-leading track record spanning a 36-year career in managed care running Pharmacy Benefit Managers, Health Plans, Hospitals and Physician Groups. He is the Chairman and Chief Executive Officer of Cedar Gate Technologies, Inc. (Cedar Gate), a value-based care performance management company, which he founded in 2014 in partnership with GTCR, the oldest private equity firm in the United States.
Prior to CGT, Mr. Snow was the CEO of Medco Health Solutions where he was responsible for the company’s turnaround, more than doubling the company’s revenues, and he facilitated its strategic merger with Express Scripts in 2012. During his time at Medco, Mr. Snow was named as one of the “Best Performing CEOs in the World” by Harvard Business Review in 2010. Before joining Medco, Mr. Snow was the president and COO of Empire Blue Cross Blue Shield, where he successfully turned the company around and took it public as WellChoice in 2002. Mr. Snow has also served in several other executive positions at Oxford Health Plans, Americhoice and American International Healthcare, to name a few.
Mr. Snow received his bachelor’s in economics from Bates College and his master’s in healthcare administration from Duke University Fuquas School of Business. He serves on several boards and is currently Chairman of the Board for Teledoc, Chairman of the Board for Duke University Fuquas School of Business Board of Visitors, Chairman of the Board for Student Affairs at Clemson University, and a member of the board for the Clemson Institute for Capitalism.
Dean joined GTCR in 2001 and is currently a Managing Director of the firm. Prior to joining GTCR, Dean was CEO and co-founder of Delray Farms, LLC, a specialty food retailer. Prior to Delray Farms, Dean was with McKinsey & Company. Dean holds an MBA with distinction from the Harvard Business School and a BS with high distinction in finance and economics from the University of Illinois, Chicago.
Dean is head of the Healthcare group at GTCR and has been instrumental in building the firm’s expertise in life sciences and medical devices. He is currently a Director of Albany Molecular, Cebatech, Cedar Gate Technologies, Dash, GreatCall, Maravai LifeSciences, Riverchase Dermatology, Regatta Medical, Rx30, Sotera, TerSera and XIFIN. Dean was previously a Director of past GTCR investments, including Actient Pharmaceuticals, ATI Physical Therapy, Cole-Parmer, Convergex, Cord Blood Registry, Crealta Pharmaceuticals, Curo Health Services, Devicor Medical Products, Ovation Pharmaceuticals, Managed Healthcare Associates and Polypore.
Dean's interest in the community is evident by his strong support of WBEZ Chicago Public Media, a non-commercial, public radio station financed primarily by listener contributions, where he serves as a board member and chair of the finance committee.
Sean joined GTCR in 2001 and is currently a Managing Director of the firm. He was previously a Consultant with The Boston Consulting Group. Sean holds an MBA from the Wharton School at the University of Pennsylvania as well as AB and BE degrees in engineering sciences from Dartmouth College.
Sean currently is a Director of Albany Molecular Research, Ceba-Tech, Cedar Gate Technologies, Correct Care Solutions, Maravai LifeSciences, Regatta, Riverchase Dermatology, Sotera and Transaction Data Systems. He was instrumental in GTCR’s past investments in Cole-Parmer, Cord Blood Registry, Devicor Medical Products, Graceway Pharmaceuticals and Ovation Pharmaceuticals.
John joined GTCR in 2006 and is a Principal in the Healthcare group. Prior to joining GTCR, he worked as an Analyst in the Healthcare investment banking group of Citigroup Global Markets in New York. John focuses on investments in healthcare technology and healthcare services for GTCR. John holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois.
He currently serves as a Director of Cedar Gate Technologies, Riverchase Dermatology and Transaction Data Systems and works closely with XIFIN and GreatCall. He was previously involved in past GTCR investment Cole-Parmer, and previously served as a Director of past GTCR investment Correctional Healthcare Companies.
Dr. Levy has directed his lifelong passion for patient-centered health systems to the creation, management, and growth of significant healthcare businesses in the US and abroad.
Dr. Levy has a specific interest and track record of achievement in complexity - patients, systems, and organizations. At Franklin Health, Dr. Levy used his insights to the problems of complex patients to create a scalable business that helped patients and their families throughout the US receive better and more satisfying care. As strategy leader at PwC (US), he led the effort to diagnose and recommend public health and hospital reform after Hurricane Katrina for the Louisiana Recovery Authority. He then went on to lead the team that helped the Department of Public Health of the state of California re-engineer their catastrophic surge response system. In both of those states he successfully engaged all of the system stakeholders - hospitals, private providers, payers, professional associations, organized labor, etc. to successful conclusion. As global leader at PwC, Dr. Levy led the firm's world-wide healthcare practice to prominence by navigating a complex matrix of domestic and international governance arrangements that resulted in PwC becoming a recognized leader in the provision of solutions to all healthcare sectors in over thirty countries. In 2014, he assumed leadership of AposTherapy, a global device company, and in 2017 became the CEO of EHE, a national preventive health company.
Dr. Levy is a widely recognized strategic thinker, who at the same time has executed on those strategies on behalf of his own enterprises, as well as for a wide variety of public and private sector entities. Drawing on an extremely deep and broad pool of business relationships, he brings global 'best-in-practice' solutions to the most important healthcare organizations in the industry. He currently sits on the boards of SulAmerica, the largest multi-line insurer in Brazil, Cedar Gate Technologies, AposTherapy Medical Assets, and EHE.
Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS). She managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency's Deputy Administrator, responsible for the implementation of the hundreds of changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit.
CMS has the second-largest budget outlay of the Federal Government, directly responsible for $1 out of every $3 spent on healthcare in the United States. The organization insures approximately a third of the population of the United States (more than 100 million beneficiaries) including the elderly, disabled, and some of the lowest income individuals in the country. CMS processes over one billion claims each year and contracts with approximately one million providers.
Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative.
Ms. Norwalk, a native of Dayton, OH, earned a juris doctor degree from the George Mason University School of Law, where she was a Dean's Scholar and an editor of the George Mason Law Review. She earned a bachelor's degree, cum laude, in economics and international relations from Wellesley College.
Lee Sacks, M.D. retired as Chief Medical Officer of Advocate Aurora Health in August 2018. In that role, he was responsible for safety, quality, population health, insurance, claims, risk management, research, and medical education. He previously served as Executive Vice President, Chief Medical Officer of Advocate Health Care since 1997. Since 1995, he has served as the founding CEO of Advocate Health Partners (now d/b/a Advocate Physician Partners), a clinically integrated network that includes over 5,000 physicians.
APP coordinates care for 1,000,000 attributable lives in commercial, Medicare, and Medicaid populations. He currently serves as a physician executive in residence for the Health Management Academy, and on the advisory board of Cardinal Analytx.
Dr. Sacks is a fellow of the Institute of Medicine, Chicago. Prior to the merger that created Advocate in 1995, he served in a variety of executive roles at Lutheran General HealthSystem. He practiced family medicine for thirteen years in suburban Chicago. Dr. Sacks earned a Bachelor of Science in chemical engineering at the University of Pennsylvania. He received his medical degree from the University of Illinois College of Medicine and completed a family practice residency at Lutheran General Hospital in Park Ridge, IL.
Victor Kats is a Managing Director and leads the Healthcare Technology Practice at Ascension Ventures (AV), a healthcare-dedicated venture and growth equity fund. Joining AV in 2009, Victor’s aim is to construct and manage a strategic portfolio of investments that have the potential to transform the healthcare industry, and enhance the experience for patients, their families and caregivers.
AV has four strategic funds with $800 million in assets under management and its 13 limited partner health systems include Ascension, Adventist Health, Carle Foundation, Catholic Health Initiatives, CentraCare, Children’s Health, Dignity, Inova, Intermountain, Mercy, Novant, OhioHealth and OSF HealthCare who collectively represent a provider network of approximately $90 billion in net patient revenue across 500 hospitals and thousands of ambulatory and post-acute facilities in 46 states. Prior to AV, Victor led Corporate Development and Strategy at Allscripts Healthcare Solutions (NASDAQ:MDRX) and Misys Healthcare Systems, the Healthcare Division of Misys PLC, and served in the Global Mergers & Acquisitions Group at Lehman Brothers.
Victor is currently a Director of Phreesia, Vivify Health, Voalte, VisitPay, Quantros and IngeniousMed and was previously Director of GetWellNetwork and MedVentive.
Victor received his B.S. degree in Business Administration with Distinction from the University of North Carolina at Chapel Hill and his MBA from The Wharton School. He is married and enjoys coaching soccer and watching Carolina basketball with his four children.
Ms. Elizabeth Connolly Alexander, known as Libby, served as Vice Chairman of the Board of Directors of Cotiviti (formerly Connolly, LLC) from July 2012 to August 27, 2018. She served as Chief Executive Officer of Connolly from 2012 to 2014 and held a variety of senior leadership positions after joining the company in 1984.
Libby established Connolly's healthcare practice in 1998 and was responsible for building it into a leader in the payment analytics and integrity space prior to the sale of the company. Cotiviti’s clients included 20 of the top 25 largest U.S. healthcare insurers, eight of the top 10 U.S. retailers, and the Centers of Medicare and Medicaid (CMS).
Libby serves on the boards of Tulane University, CT Fund for the Environment|Save the Sound, and the Eaglebrook School. She holds a BA from Tulane University.